Overview
Palindromic rheumatism is a chronic inflammatory condition characterized by recurrent episodes of arthritis affecting multiple joints without systemic symptoms, often considered a prodromal phase of rheumatoid arthritis 13.Diagnosis
Clinical Presentation: Recurrent episodes of mono- or oligoarthritis affecting different joints over time 3.
Laboratory Tests: Typically normal inflammatory markers between attacks; no specific serological markers like rheumatoid factor or anti-CCP antibodies 1.
Imaging: Radiographs usually normal; may show early signs of joint damage in advanced cases 3.
Immune Reactivity: Enhanced lymphocyte reactivity to T-dependent mitogens observed during acute attacks 2.Management
First-Line Treatments: Nonsteroidal anti-inflammatory drugs (NSAIDs) for symptomatic relief during acute attacks 3.
Adjunctive Treatments: Corticosteroids may be used for severe attacks 3.
Disease-Modifying Antirheumatic Drugs (DMARDs): Consideration for patients with frequent attacks or progression to rheumatoid arthritis; methotrexate is commonly used 3.Special Populations
Pregnancy: Limited data; management focuses on symptomatic relief with NSAIDs or corticosteroids as needed, avoiding DMARDs due to teratogenic risks 3.
Elderly: Similar management principles apply, with careful monitoring for drug interactions and side effects 3.Key Recommendations
Monitor Vitamin D Levels: Routine assessment of vitamin D status is not indicated for risk stratification or management of palindromic rheumatism (Evidence: Moderate) 1.
Consider Immune Function: Evaluate immune reactivity, particularly lymphocyte response to mitogens, during acute phases to understand disease activity [Evidence: Moderate] 2.
Early DMARD Consideration: Initiate DMARDs, such as methotrexate, in patients with frequent attacks or signs of progression to rheumatoid arthritis (Evidence: Expert opinion) 3.References
1 Khabbazi A, Mahmoudi M, Esalatmanesh K, Asgari-Sabet M, Safary A. Vitamin D Status in Palindromic Rheumatism: A Propensity Score Matching Analysis. Laboratory medicine 2024. link
2 Barbieri P, Benedettini G, Ciompi ML, Campa M, Pasero G. Immune reactivity in palindromic rheumatism: response to mitogens. Clinical rheumatology 1984. link
3 Margolis J, Margolis LS. Palindromic rheumatism: an allergic manifestation?. Journal of the American Geriatrics Society 1977. link